196 related articles for article (PubMed ID: 17979520)
1. No association of Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in susceptibility to gallbladder cancer.
Srivastava A; Pandey SN; Pandey P; Choudhuri G; Mittal B
DNA Cell Biol; 2008 Mar; 27(3):127-32. PubMed ID: 17979520
[TBL] [Abstract][Full Text] [Related]
2. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
3. Association of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with primary glaucoma in Saudi population.
Al-Shahrani H; Al-Dabbagh N; Al-Dohayan N; Arfin M; Al-Asmari M; Rizvi S; Al-Asmari A
BMC Ophthalmol; 2016 Sep; 16(1):156. PubMed ID: 27585654
[TBL] [Abstract][Full Text] [Related]
4. PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females.
Rai R; Sharma KL; Misra S; Kumar A; Mittal B
Gene; 2013 Nov; 530(2):172-7. PubMed ID: 23988503
[TBL] [Abstract][Full Text] [Related]
5. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
Srivastava A; Pandey SN; Choudhuri G; Mittal B
Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
[TBL] [Abstract][Full Text] [Related]
7. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
8. Risk of colorectal cancer associated with the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the Kashmiri population.
Sameer AS; Shah ZA; Nissar S; Mudassar S; Siddiqi MA
Genet Mol Res; 2011 Jun; 10(2):1200-10. PubMed ID: 21732284
[TBL] [Abstract][Full Text] [Related]
9. Significant association of methylenetetrahydrofolate reductase single nucleotide polymorphisms with prostate cancer susceptibility in taiwan.
Wu HC; Chang CH; Tsai RY; Lin CH; Wang RF; Tsai CW; Chen KB; Yao CH; Chiu CF; Bau DT; Lin CC
Anticancer Res; 2010 Sep; 30(9):3573-7. PubMed ID: 20944139
[TBL] [Abstract][Full Text] [Related]
10. Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.
Oh D; Kim NK; Jang MJ; Kim HC; Lee JH; Lee JA; Ahn MJ; Kim CS; Kim HS; Park S; Chio HS; Min YH;
Anticancer Res; 2007; 27(5A):3419-24. PubMed ID: 17970089
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus.
Zhou TB; Drummen GP; Jiang ZP; Li HY
Ren Fail; 2015; 37(8):1247-59. PubMed ID: 26161693
[TBL] [Abstract][Full Text] [Related]
13. Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer.
Srivastava A; Pandey SN; Choudhuri G; Mittal B
Mol Genet Metab; 2008 May; 94(1):83-9. PubMed ID: 18178499
[TBL] [Abstract][Full Text] [Related]
14. Complement receptor 1 (A3650G RsaI and intron 27 HindIII) polymorphisms and risk of gallbladder cancer in north Indian population.
Srivastava A; Mittal B
Scand J Immunol; 2009 Dec; 70(6):614-20. PubMed ID: 19906204
[TBL] [Abstract][Full Text] [Related]
15. The association of methylenetetrahydrofolate reductase genotypes with the risk of childhood leukemia in Taiwan.
Pei JS; Hsu CM; Tsai CW; Chang WS; Ji HX; Hsiao CL; Miao CE; Hsu YN; Bau DT
PLoS One; 2015; 10(3):e0119776. PubMed ID: 25793509
[TBL] [Abstract][Full Text] [Related]
16. Association of Methylenetetrahydrafolate Reductase Gene Polymorphism (MTHFR) in Patients with Gallbladder Cancer.
Dixit R; Singh G; Pandey M; Basu S; Bhartiya SK; Singh KK; Shukla VK
J Gastrointest Cancer; 2016 Mar; 47(1):55-60. PubMed ID: 26687138
[TBL] [Abstract][Full Text] [Related]
17. Retrospective case-control study of correlation between MTHFR gene and OSCC risk in North India.
Naqvi H; Ahmad MK; Hussain SR; Gupta S; Waseem M; Mahdi AA
Clin Oral Investig; 2017 Jul; 21(6):1929-1934. PubMed ID: 27774577
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cancer susceptibility: a genetic marker in the methylenetetrahydrofolate reductase gene.
Kureshi N; Ghaffar S; Siddiqui S; Salahuddin I; Frossard PM
ORL J Otorhinolaryngol Relat Spec; 2004; 66(5):241-5. PubMed ID: 15583437
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
Senhaji N; Serbati N; Diakité B; Arazzakou S; Hamzi K; Badre W; Nadifi S
Gene; 2013 May; 521(1):45-9. PubMed ID: 23542077
[TBL] [Abstract][Full Text] [Related]
20. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
